Unknown

Dataset Information

0

Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus.


ABSTRACT: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agent for the treatment of type 2 diabetes mellitus. They increase endogenous levels of incretin hormones, which stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and contribute to reducing postprandial hyperglycemia. Although DPP-4 inhibitors have similar benefits, they can be differentiated in terms of their chemical structure, pharmacology, efficacy and safety profiles, and clinical considerations. Gemigliptin (brand name: Zemiglo), developed by LG Life Sciences, is a potent, selective, competitive, and long acting DPP-4 inhibitor. Various studies have shown that gemigliptin is an optimized DPP-4 inhibitor in terms of efficacy, safety, and patient compliance for treatment of type 2 diabetes mellitus. In this review, we summarize the characteristics of gemigliptin and discuss its potential benefits in clinical practice.

SUBMITTER: Kim SH 

PROVIDER: S-EPMC5069390 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus.

Kim Sung-Ho SH   Yoo Jung-Hwa JH   Lee Woo Je WJ   Park Cheol-Young CY  

Diabetes & metabolism journal 20160912 5


Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agent for the treatment of type 2 diabetes mellitus. They increase endogenous levels of incretin hormones, which stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and contribute to reducing postprandial hyperglycemia. Although DPP-4 inhibitors have similar benefits, they can be differentiated in terms of their chemical structure, pharmacology, efficacy and safety profiles, and clinical consid  ...[more]

Similar Datasets

| S-EPMC4910510 | biostudies-literature
| S-EPMC3351851 | biostudies-literature
| S-EPMC5483423 | biostudies-other
| S-EPMC4980637 | biostudies-literature
| S-EPMC5027002 | biostudies-other
| S-EPMC5838201 | biostudies-literature
| S-EPMC5501211 | biostudies-literature
| S-EPMC7470242 | biostudies-literature
| S-EPMC7328526 | biostudies-literature
| S-EPMC8369212 | biostudies-literature